| Literature DB >> 33791289 |
Rosa Sagita1, Wim J Quax1, Kristina Haslinger1.
Abstract
The bioprospecting of secondary metabolites from endophytic fungi received great attention in the 1990s and 2000s, when the controversy around taxol production from Taxus spp. endophytes was at its height. Since then, hundreds of reports have described the isolation and characterization of putative secondary metabolites from endophytic fungi. However, only very few studies also report the genetic basis for these phenotypic observations. With low sequencing cost and fast sample turnaround, genetics- and genomics-based approaches have risen to become comprehensive approaches to study natural products from a wide-range of organisms, especially to elucidate underlying biosynthetic pathways. However, in the field of fungal endophyte biology, elucidation of biosynthetic pathways is still a major challenge. As a relatively poorly investigated group of microorganisms, even in the light of recent efforts to sequence more fungal genomes, such as the 1000 Fungal Genomes Project at the Joint Genome Institute (JGI), the basis for bioprospecting of enzymes and pathways from endophytic fungi is still rather slim. In this review we want to discuss the current approaches and tools used to associate phenotype and genotype to elucidate biosynthetic pathways of secondary metabolites in endophytic fungi through the lens of bioprospecting. This review will point out the reported successes and shortcomings, and discuss future directions in sampling, and genetics and genomics of endophytic fungi. Identifying responsible biosynthetic genes for the numerous secondary metabolites isolated from endophytic fungi opens the opportunity to explore the genetic potential of producer strains to discover novel secondary metabolites and enhance secondary metabolite production by metabolic engineering resulting in novel and more affordable medicines and food additives.Entities:
Keywords: biosynthetic gene cluster; biosynthetic pathway elucidation; culture-dependent; culture-independent; genome mining; secondary metabolite discovery
Year: 2021 PMID: 33791289 PMCID: PMC8005728 DOI: 10.3389/fbioe.2021.649906
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Figure 1Schematic overview of secondary metabolite discovery and pathway elucidation steps discussed in this review. All steps of the cycle are required to fully connect phenotypic observations to the genotype of an organism and vice versa. Key technologies depicted for each step are: whole genome sequencing (WGS), amplicon sequencing after PCR amplification, and transcriptomics and reverse transcriptase quantitative PCR (RT-qPCR) for genotyping; retro-biosynthesis, homology searches, and comparative genomics to generate hypotheses on the link between genotype and phenotype and vice versa; chromatography- and bioassay-guided metabolite discovery and analysis, possibly coupled to differential culturing of the native host (OSMAC) for phenotyping; gene activation and deletion in the native host as well as recombinant expression of target genes in heterologous hosts for experimental verification. Created with graphical elements from BioRender.com.
Figure 2Structures of the bioactive secondary metabolites isolated from endophytic fungi and named in this review.
Possible sources of error when working with endophytic fungi and commonly used or suggested preventive measures.
| 1 | Isolation of fungus | • Sampling from diseased plants | • Properly document sampling site and deposit voucher specimen. |
| 2 | Secondary metabolite measurement from cultivated endophytic fungi | False positive detection caused by the carry-over of plant metabolites or enzymes | • Perform time course experiment to observe the secondary metabolite titer increase with biomass formation; possibly observed over several passages. |
| 3 | PCR amplification of putative biosynthetic genes | Contamination of extracted DNA with plant DNA, or the DNA of other microorganisms | • Include water controls during DNA extraction and PCR to control for reagent contamination |
Successful studies in linking phenotype and genotype of the related bioactive secondary metabolites from plant endophytic fungi supported by experimental verifications.
| 1 | Pestheic acid and iso-A82775C (precursors of chloropupu-keananin) | Retro biosynthesis, BGC homology | Detection of target compound by LC-MS and bioassay-guided strategy in native host | Transcript analysis and WGS | Gene knock-out and rescue by complementation in native host; heterologous expression in | Liu et al., | |||
| 2 | Swainsonine | Comparative genomics, retro biosynthesis, BGC homology | Detection of target compound by LC-MS in native host | WGS | Gene knock-out and rescue by complementation in native host. | Braun et al., | |||
| 3 | Putative perylenequinones cluster | Perylenequinones, especially Hypocrellin A | Retro biosynthesis, BGC homology | Detection of target compounds by HPLC in native host | WGS and transcript analysis | Gene activation by elicitor overexpression combined with transcriptomic analysis in native host. | Yang et al., | ||
| 4 | Mormon tea | Radicicol and Monocillin I | Retro biosynthesis, BGC homology | Bioassay-guided discovery in native host | PCR amplification | Gene knock-out in native host and targeted inactivation of a putative cluster specific regulator. | Turbyville et al., | ||
| 5 | ND | Leucinostatin A and B | Retro biosynthesis, BGC homology | Detection of target compound by LC-MS in native host | WGS | Gene knock-out by homologous recombination and overexpression of cluster specific regulator in native host. | Fukushima et al., | ||
| 6 | Nodulisporic acid F | Retro biosynthesis, BGC homology | Detection of target compounds by HPLC in native host | WGS | Heterologous expression of BGC in | Nicholson et al., | |||
| 7 | ND | 1,8-cineole | Biosynthetic gene homology | Detection of target compounds by GC-MS in native host | WGS | Heterologous expression in | Shaw et al., | ||
| 1 | Chevalone E and its derivatives | Retro biosynthesis, BGC homology | Untargeted chromatography-guided isolation from heterologous host | WGS | Heterologous expression of BGC | Wang et al., | |||
| 2 | DHN melanin | BGC homology | Targeted chromatography-guided isolation from heterologous and native host | WGS | Gene deletion (BGC genes and global regulators) in native host; pathway reconstitution and gene deletion in heterologous host | Zhang et al., | |||
| 3 | alk(en)yl-resorcinol polyketides | Biosynthetic gene homology | Targeted chromatography-guided isolation from heterologous host | WGS | Heterologous expression of | Yan et al., | |||
ND, no data.
Figure 3Illustration of four BGCs discovered in studies starting from phenotypic observation (A–D) and two BGCs from genotypic observation (E,F) including the experimental strategies used to verify and characterize their functions. (A) pta giving rise to pestheic acid (20), (B) iac encoding enzymes for isoA82775C (21), (C) SWN shown to be essential for swainsonine (2) production, (D) lcs giving rise to leucinostatin (13), (E) cle involved in the biosynthesis of chevalone E (18a) and its derivatives (18b, 18c), and (F) pfma essential for the production of 1,8 DHN (25) melanin. Genes are indicated as arrowheads, with names of genes encoding key enzymes highlighted in dark blue, (putative) regulatory genes in light blue. Fill and pattern of arrowheads depict experimental evidence (native host: light green—gene knock-out, dark green—gene knock-out followed by rescue via gene complementation, diagonal cross—promoter engineering, no pattern with white fill—no experimental data, brown—precursor feeding experiment; heterologous host: yellow—gene knock-out, horizontal stripe—promoter engineering, pink—in vitro assay, orange—precursor feeding experiment). Genes located within BGC are connected with a solid black line while genes outside the BGC with dotted gray line.
List of endophytic fungi subject to whole genome sequencing projects referenced in the literature.
| Resveratrol | Antitumor, cardioprotective, antioxidant, anti-inflammatory | Lu et al., | |||
| NA | (±)-Alternamgin | Antiproliferative | Wu J. C. et al., | ||
| NA | Swainsonine | Anticancer | Lu et al., | ||
| Oxygenated cyclohexanone | Antimicrobial | Jeon et al., | |||
| NA | Chevalone E | Anticancer | Wang et al., | ||
| ND | ND | Gianoulis et al., | |||
| Lijiquinone 1 | Anticancer and Antifungal | Cain et al., | |||
| ND | ND | Knapp et al., | |||
| Huperzine A | Memory enhancer | Kang et al., | |||
| ND | ND | Rogério et al., | |||
| ND | ND | Gramaje et al., | |||
| grapevine rootstock 110 Richter | ND | ND | Gramaje et al., | ||
| ND | ND | Kim et al., | |||
| ND | ND | Bhargavi et al., | |||
| Mycoepoxydiene | Anticancer | Tulsook et al., | |||
| Indole derivatives | Plant growth factor | Sun et al., | |||
| Red to purple pigments | Antimicrobial | Kim et al., | |||
| Lateropyrone | Antibacterial | Akone et al., | |||
| C-glycosylated dialkylresorcinol derivatives and glycosylated anthraquinone | Anti-inflammatory | Kim et al., | |||
| ND | ND | Lai et al., | |||
| 1,8-cineole | Essential oil | Shaw et al., | |||
| Barley seeds | ND | ND | Wu et al., | ||
| Barley seeds | ND | ND | Wu et al., | ||
| Barley seeds | ND | ND | Wu et al., | ||
| Nodulisporic acids | Insecticide | Nicholson et al., | |||
| ND | Swainsonine | Anticancer | Gao et al., | ||
| ND | Swainsonine | Anticancer | Cook et al., | ||
| ND | ND | Lebreton et al., | |||
| Diketopiperazine | Antibiotic | Carrieri et al., | |||
| Paclitaxel | Anticancer | Yang et al., | |||
| Hypocrellins | Antifungal | Meng et al., | |||
| Meroterpenoids | Anti-inflammatory and Antibacterial | Fill et al., | |||
| Polyphenol and flavonoid | Antioxidants | Mefteh et al., | |||
| Citrinin | Antibiotic | Schmidt-Heydt et al., | |||
| NA | Azaphilones | Antiproliferative, Anti-inflammatory, and Antioxidant | Wei et al., | ||
| Huperzine A | Alzheimer treatment | Kang et al., | |||
| ND | ND | Knapp et al., | |||
| Chloropupukeananins | Antimicrobial, Antitumor, and Anti-HIV activities | Wang et al., | |||
| Ficiolide K | ND | Wu et al., | |||
| Pestaloficins | ND | Zheng et al., | |||
| Rugulosin | Anti-insect | Walker et al., | |||
| ND | ND | Rodrigues et al., | |||
| ND | ND | Rodrigues et al., | |||
| ND | ND | Guarnaccia et al., | |||
| ND | ND | Guarnaccia et al., | |||
| ND | ND | Larriba et al., | |||
| NA | Cyclopeptide and Rotenoids | Anticancer | Sobreira et al., | ||
| ND | Leucinostatins | Antibiotic and Antitumor | Wang et al., | ||
| Phytohormones | Promoting plant growth | Firrincieli et al., | |||
| ND | ND | Yang et al., | |||
| ND | ND | Zuccaro et al., | |||
| alk(en)yl-resorcinol polyketides | Antibacteria | Yang H. et al., | |||
| Perylenequinones | Anticancer, antibacterial, antiviral, and memory enhancer | Liu et al., | |||
| ND | ND | Heinig et al., | |||
| ND | ND | Gazis et al., |
The columns contain the following information: fungal strain, host plant, accession number with the respective source database indicated by footnote, observed bioactive secondary metabolites and their bioactivity, and primary literature reference. All entries were assembled at contig or scaffold level.
ND, no data.
NCBI.
Not published, only mentioned in literature.
JGI.
REEIS.